Erythrasma

L12_ERYTHRASMA

erythrasma: a skin disease that causes brown, scaly skin patches. It is caused by the Gram-positive bacterium Corynebacterium minutissimum. It is prevalent among diabetics and the obese, and in warm climates; it is worsened by wearing occlusive clothing.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L08.1 Hospital discharge: ICD-9 — 390 Cause of death: ICD-10 — L08.1 Cause of death: ICD-9 — 390 2 out of 7 registries used, show all original rules.	99
4. Check minimum number of events None	99
5. Include endpoints None	99
6. Filter based on genotype QC (FinnGen only)	87

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: L08
Name in latin: Erythrasma

NAME	L12_ERYTHRASMA
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L081
HD_ICD_9	390
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L081
COD_ICD_9	390
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythrasma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	476	191	281
Only index persons	408	160	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	50.66	50.13	50.99
Only index persons	47.94	47.52	48.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	87	28	59
Unadjusted period prevalence (%)	0.02	0.01	0.03
Median age at first event (years)	55.29	57.69	54.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
92: Matched controls
920

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L08.1

ICD-10 Finland

Erythrasma

+∞

111.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

5.4

13.7

106

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

4.6

11.3

127

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.7

9.7

3900A

ICD-9 Finland

Rheumatic fever without mention of heart involvement[FEBRIS RHEUMATICA, MORBO CORDIS NON INDICATO]

+∞

7.4

D07AC01

ATC

betamethasone; topical

3.1

6.7

216

D07AB02

ATC

hydrocortisone butyrate; topical

3.1

6.0

160

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

3.17

4.74

1.4

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

237

2.42

4.10

5.1

2.6

36.03

49.85

e6/l

0.18

180

(40768443) Skin Pathology biopsy report

4.55

4.10

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

132

2.61

3.99

1.1

1.3

35.17

14.28

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

200

2.42

3.95

5.2

2.5

0.32

0.33

e6/l

0.02

141

(3013650) Neutrophils [#/volume] in Blood by Automated count

425

2.29

3.45

12.2

9.9

3.90

4.06

e9/l

0.25

373

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

257

2.17

3.22

5.6

2.8

—

(3023368) Bacteria identified in Blood by Culture

185

2.22

3.13

4.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

6.21

3.08

1.1

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

6.21

3.08

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

2.48

2.99

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

157

2.24

2.97

1.4

1.8

1.12

1.52

mg/l

0.37

131

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

344

2.08

2.97

10.8

7.6

1.21

mmol/l

0.37

304

(3006504) Eosinophils/Leukocytes in Blood

354

2.08

2.95

8.5

6.0

2.77

2.86

0.13

337

(3001604) Monocytes [#/volume] in Blood

392

2.10

2.94

8.0

6.1

0.62

0.57

e9/l

0.62

338

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

107

2.39

2.87

4.9

2.4

1.54

2.06

e6/l

0.16

(3019069) Monocytes/Leukocytes in Blood

357

2.05

2.85

8.6

6.0

9.02

8.78

0.25

341

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

115

2.33

2.82

4.9

2.4

0.69

0.62

e6/l

0.06

(3022096) Basophils/Leukocytes in Blood

352

2.01

2.71

8.5

6.0

0.67

0.69

0.07

334

(3018095) Leukocytes [#/volume] in Urine

271

2.01

2.69

6.0

3.2

19.26

161.54

e6/l

0.58

186

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

142

2.16

2.58

1.2

1.3

54.75

46.89

iu/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

6.53

2.40

1.0

1.3

27.40

22.25

ng/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.71

2.33

1.9

1.7

1.07

1.22

g/l

—

(3012544) pH of Venous blood

2.48

2.32

6.5

4.2

7.39

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.26

2.31

9.3

8.0

102.84

104.23

mmol/l

0.52

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

173

1.99

2.26

1.6

1.4

1.80

2.02

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

157

2.02

2.25

1.8

1.4

3.24

2.58

g/l

0.55

102

(42870588) Differential panel, method unspecified - Blood

249

1.90

2.25

5.8

6.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.37

2.24

1.3

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

111

2.16

2.24

1.3

1.4

546.67

375.00

titre

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

142

2.04

2.22

1.7

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

3.40

2.15

1.5

4.1

13.00

21.45

u/ml

—

(3000991) Gas panel - Venous blood

2.45

2.02

8.8

9.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3.36

1.92

2.0

1.6

0.21

0.26

g/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

118

2.01

1.90

1.9

1.8

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.74

1.86

1.3

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.12

1.85

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

4.34

1.85

1.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

186

1.82

1.78

8.0

4.8

—

(3025941) Bacteria identified in Stool by Culture

2.68

1.73

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.55

1.68

1.7

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.04

1.63

1.7

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.07

1.60

1.7

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2.72

1.55

1.0

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

625

1.81

1.49

25.4

17.7

13.74

13.57

0.42

616

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.62

1.48

1.1

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.84

1.46

5.8

5.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

297

1.61

1.40

2.2

1.9

93.98

93.23

pmol/l

0.04

170

(3017732) Neutrophils [#/volume] in Blood

1.92

1.40

3.8

3.1

4.46

7.23

e9/l

0.50

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.41

1.30

6.0

3.1

0.63

0.70

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

2.88

1.30

2.6

2.1

48.80

127.50

ug/min

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.34

1.28

6.0

3.0

1.20

1.49

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

119

1.75

1.24

1.8

—

(3025159) Blasts/Leukocytes in Blood

2.06

1.23

8.3

4.3

0.20

0.13

—

(40758558) Short blood count panel - Blood

224

1.58

1.19

5.0

6.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

279

1.55

1.18

4.4

3.3

24.60

62.80

ng/l

1.21

191

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2.58

1.16

1.0

1.3

596.00

474.40

mg/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.08

1.16

1.9

1.6

—

(3000494) Fungus identified in Specimen by Culture

105

1.76

1.16

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.94

1.15

1.7

1.8

12.77

10.66

g/l

0.46

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.21

1.08

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2.34

1.04

1.0

1.2

—

(36660697) Celiac disease serology panel - Serum

1.91

1.03

1.5

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

315

1.48

1.01

10.9

6.7

1.21

mmol/l

0.42

303

(3004789) Transferrin [Mass/volume] in Serum or Plasma

110

1.67

0.99

5.0

2.3

2.40

2.33

g/l

0.16

101

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2.02

0.99

2.6

2.2

43.29

41.45

u/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.02

0.99

2.0

1.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.99

0.0

3.1

—

89.27

—

(3012516) Albumin [Mass/volume] in Urine

225

1.49

0.95

5.0

3.6

84.25

80.44

mg/l

0.02

164

(3022948) Iron [Moles/volume] in Serum or Plasma

120

1.62

0.94

4.9

2.4

11.86

14.62

umol/l

0.81

113

(3032080) INR in Blood by Coagulation assay

338

1.45

0.93

18.6

12.8

1.16

1.24

inr

0.52

271

(3044640) Blood type and Crossmatch panel - Blood

235

1.48

0.93

2.7

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.22

0.93

1.8

1.3

—

(3015736) pH of Urine

320

1.44

0.91

4.6

3.0

6.25

6.12

0.33

179

(3017181) Myelocytes/Leukocytes in Blood

1.82

0.91

10.3

3.7

0.33

1.20

—

(1761868) Lipid panel - Serum or Plasma

330

1.44

0.91

5.1

3.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

540

1.45

0.88

4.9

3.9

14.66

14.63

pmol/l

0.03

501

(3026008) Bacteria identified in Urine by Culture

166

1.51

0.87

5.2

2.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

167

1.50

0.84

2.0

2.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.80

0.0

3.3

—

189.92

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.24

0.77

1.8

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2.14

0.76

1.4

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

330

1.38

0.74

3.2

2.6

—

estimate

—

(3021601) Nitrite [Presence] in Urine by Test strip

399

1.36

0.72

4.7

3.4

0.00

estimate

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.97

0.72

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

238

1.39

0.69

7.2

4.1

14.10

12.18

mg/mmol

0.07

167

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

174

1.43

0.69

2.3

2.0

—

(3021589) Normoblasts [#/volume] in Blood

333

1.36

0.69

15.1

11.1

0.00

0.01

e9/l

0.50

262

(3009261) Glucose [Presence] in Urine by Test strip

412

1.35

0.67

5.1

3.5

0.00

estimate

—

(3014051) Protein [Presence] in Urine by Test strip

230

1.38

0.67

4.3

2.6

—

0.29

—

(3035350) Ketones [Presence] in Urine by Test strip

405

1.33

0.63

5.2

3.4

0.00

estimate

—

(3034770) Mitochondria Ab [Titer] in Serum

1.70

0.62

1.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.61

0.0

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

740

1.48

0.58

22.3

14.4

19.71

22.75

mg/l

0.46

604

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.71

0.58

1.0

1.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.51

0.55

8.8

9.0

5.51

5.02

kpa

0.46

(3027801) Oxygen [Partial pressure] in Arterial blood

1.51

0.55

8.8

9.0

13.91

12.02

kpa

0.39

(3019977) pH of Arterial blood

1.51

0.55

8.8

9.0

7.41

7.43

—

(3041096) Erythrocytes [Presence] in Urine by Automated

237

1.33

0.55

4.7

3.1

0.00

estimate

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.58

0.54

2.8

5.1

4.12

4.82

pmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

147

1.37

0.50

1.3

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.65

0.44

2.0

2.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.59

0.43

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1.54

0.42

1.0

1.2

—

(3027008) Opiates [Presence] in Urine

1.54

0.42

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

1.54

0.42

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

1.54

0.42

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.50

0.41

2.8

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.6

—

15.40

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.45

0.40

1.2

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.39

0.0

1.8

—

(3003694) ABO and Rh group [Type] in Blood

212

1.25

0.35

1.3

1.4

—

(40768804) Tissue Pathology biopsy report

289

1.22

0.35

2.0

1.9

—

(21494755) Public health laboratory ask at order entry panel

0.69

0.33

1.1

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

492

1.18

0.29

2.5

3.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.27

0.28

2.8

4.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.22

0.26

1.9

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.20

0.25

1.2

1.6

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.8

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

0.21

0.0

1.5

—

12.82

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

65.88

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.20

0.0

1.6

—

(3019225) pH of Specimen

1.22

0.18

4.3

7.33

7.30

—

(40761536) Microorganisms panel - Urine sediment

1.22

0.18

7.9

3.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.20

0.18

1.1

1.6

42.00

40.19

nmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

294

1.14

0.18

4.6

4.1

25.50

21.48

0.70

136

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.16

0.17

9.5

6.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

670

1.12

0.13

6.6

4.8

2.09

1.85

mu/l

0.89

625

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

319

1.10

0.13

5.0

3.4

0.00

0.03

estimate

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.18

0.12

1.7

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

754

1.13

0.10

26.3

16.3

3.96

3.99

mmol/l

0.50

741

(3000492) Spirometry study

1.17

0.10

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

755

1.12

0.09

26.1

16.3

139.95

139.79

mmol/l

0.22

745

(3019060) Gas panel - Arterial blood

1.07

0.09

3.6

5.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.15

0.09

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

764

0.90

0.08

7.2

5.6

2.71

mmol/l

0.01

721

(3022145) Colonoscopy Study observation

1.15

0.08

1.7

1.4

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

0.77

0.08

1.2

1.3

—

(40761511) CBC panel - Blood by Automated count

779

1.10

0.06

20.3

13.1

—

(3042936) Bacteria identified in Isolate by Culture

110

1.10

0.05

1.9

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

221

0.94

0.05

3.6

3.0

0.55

0.73

ug/l

1.18

145

(3019150) Specific gravity of Urine by Refractometry

190

1.07

0.04

4.9

3.1

1.02

kg/l

1.55

113

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

719

0.95

0.03

6.4

4.9

6.28

5.94

mmol/l

0.90

673

(3029937) Albumin [Presence] in Urine by Test strip

219

1.01

0.00

4.6

3.6

0.00

estimate

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

0.00

-0.00

0.0

4.6

—

25.60

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.7

—

7.20

—

(3026361) Erythrocytes [#/volume] in Blood

822

1.10

-0.00

34.6

21.7

4.61

4.64

e12/l

0.16

808

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

822

1.10

-0.00

35.0

21.8

138.46

139.87

g/l

0.40

817

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

-0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

53.97

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

-0.00

0.0

1.2

—

1.61

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.3

—

(40768793) Breast Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.00

-0.00

2.1

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

30.17

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

822

1.10

-0.00

35.6

22.1

41.38

41.55

0.14

816

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.5

—

7.47

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

25.88

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

0.89

-0.00

2.0

1.9

3.01

3.40

mmol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.6

—

0.00

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3010813) Leukocytes [#/volume] in Blood

822

1.10

-0.00

34.6

21.7

6.80

6.64

e9/l

0.29

808

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

73.38

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.0

—

(3002256) Pathology report gross observation

0.99

-0.00

1.5

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

969.40

—

(3035941) MCH [Entitic mass]

822

1.10

-0.00

34.5

21.6

30.11

30.38

0.66

816

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.1

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

821

1.11

-0.00

34.6

21.7

90.24

90.84

0.58

815

(4035726) Immunohistochemistry procedure

1.02

-0.00

1.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHRASMA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHRASMA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHRASMA – Erythrasma

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythrasma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints